SEC Form 4/A · accession 0000899243-18-004341
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jake Bauer
Officer — See Remarks
Period of report
Jan 9, 2018
Accepted (ET)
Feb 15, 2018 · 8:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2018 | M | 5,000 | $12.25 | A | 66,777 | D | |
| Common Stock | Jan 9, 2018 | S | 5,000 | $45.00 | D | 61,777 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $12.25 | Jan 9, 2018 | M | 5,000 | D | — | Jan 17, 2027 | Common Stock | 5,000 | 54,850 | D |
Explanation of responses
- F1This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2The shares underlying the option vest in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Remarks
Senior Vice President, Finance and Corporate Development